Palladium Warehouse & Delivery — Week of November 16, 2026

Palladium Physical Market Brief — November 16, 2026

Executive summary

  • Light November delivery cycle so far: As of today (intent date 2026-11-16), the NYMEX November 2026 palladium contract shows 5 notices issued, 5 stopped, and 9 month-to-date — a small cycle compared with the October contract's 86 MTD at its final observed print.
  • Full take-up on notices: Issued equals stopped on every day in the dataset (5/5 today, 2/2 on Oct 30, 2/2 on Oct 29, etc.), meaning every notice issued has been stopped for delivery — but on very small volumes.
  • Settlements sliding: The November contract settled at $971.80 today vs. $1,000.60 (Oct 29), $984.60 (Oct 30), and the October contract at $1,167.20 on Oct 5 — a decline of roughly 17% across the observed window.
  • Positioning vs. physical: Managed money is heavily net short (see cross-check below), yet physical delivery activity is too small to either confirm physical tightness or stress. No clear divergence signal — just thin delivery flow in a falling market.

Delivery intentions (today + MTD context)

All activity is in the November 2026 Palladium Futures (NYMEX) contract; standard 100-troy-oz NYMEX contract, so today's cycle totals ~900 oz MTD.

Intent date Contract Issued Stopped MTD Settlement Delivery date
2026-11-16 Nov 2026 5 5 9 $971.80 2026-11-18
2026-10-30 Nov 2026 2 2 4 $984.60 2026-11-03
2026-10-29 Nov 2026 2 2 2 $1,000.60 2026-11-02
2026-10-15 Oct 2026 5 5 86 $1,121.00 2026-10-19
2026-10-08 Oct 2026 5 5 78 $1,114.90 2026-10-12
2026-10-05 Oct 2026 1 1 73 $1,167.20 2026-10-07
  • Today: 5 new notices issued and stopped, lifting November-cycle MTD from 4 (Oct 30) to 9 — roughly a tenth of the October cycle's 86-contract total at a comparable late-cycle stage.
  • Pace: The November cycle ramped slowly (2 → 4 → 9), and with delivery on Nov 18, the cycle appears on track to be far smaller than October's.
  • No firm detail published: the firms list is empty in the feed, so no counterparty visibility is available.
  • Track ongoing changes on the warehouse & delivery stream.

Warehouse stocks

  • Warehouse stocks are null in the feed. CME/NYMEX does not publish warehouse stock data for palladium in this dataset, so above-ground exchange-inventory trends cannot be assessed here — delivery intentions are the only physical signal available for this metal.

COT cross-check (as of 2026-11-13)

  • Managed money: 4,784 long vs. 20,498 short → net short 15,714 contracts, roughly 53% of the 29,729 open interest — a heavily crowded bearish stance.
  • Producers/merchants: 3,745 long vs. 1,276 short → net long 2,469 — hedgers/commercials sitting net long, which is unusual and worth monitoring.
  • Read-through vs. physical: Specs are aggressively short into a falling market ($1,167 → $971.80 over the window), while delivery flow is tiny but fully stopped. The physical tape neither corroborates a physical-driven selloff nor signals a squeeze — the divergence risk is that the crowded short is priced off momentum, not delivery stress. Full detail: COT stream.

Risks and watchpoints

  • Crowded managed-money short (−15,714): if any physical catalyst emerges, short-covering could be abrupt given positioning is large relative to open interest.
  • Delivery cycle size: watch whether the November cycle finishes well below October's 86 contracts — shrinking cycles alongside falling prices would suggest weak end-user take-up rather than supply stress.
  • Net-long commercials (2,469): producer/merchant net long positioning alongside spec shorts is atypical; a reversal by either group would be a signal.
  • No warehouse visibility: with warehouse stocks unpublished, there is no exchange-inventory check on whether the paper-short positioning has physical backing.
  • Momentum risk: continued settlement declines ($984.60 → $971.80 into today) could pressure further notice issuance — or suppress it if longs simply liquidate rather than stand for delivery.

This brief is market analysis, not personalized financial advice.

Arc Research publishes market data and research for information only. It is not investment, trading or financial advice, and Arc Research is not a registered investment adviser or commodity trading advisor. Futures and options trading carries a substantial risk of loss. Hypothetical, backtested and paper results are not actual trading. Read the full disclaimer · Terms of Service · Affiliates